Article
Effect of epidermal growth factor receptor mutations on the response to epidermal growth factor receptor tyrosine kinase inhibitors: target-based populations for target-based drugs.
Clinical lung cancer - 1 Dec 2004
Calvo Emiliano, Rowinsky Eric K
Abstract excerpt
The recent identification of somatic mutations in the epidermal growth factor receptor (EGFR)-tyrosine kinase (TK) domain of tumor samples from patients with non-small-cell lung cancer (NSCLC) that portend robust response to small-molecule inhibitors of EGFR TK is a watershed event in the fields of lung cancer genetics and therapeutic agents. In addition to paralleling what is already known about c-kit mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
